Talis Biomedical Corporation Operating Lease Right-of-Use Assets
Talis Biomedical Corporation had Operating Lease Right-of-Use Assets of $7.91 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-08-19
- 2024-06-30: Operating Lease, Right-of-Use Asset $7.91M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $8.15M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $12.42M.
- 2023-09-30: Operating Lease, Right-of-Use Asset $12.82M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-06-30 | $7.91M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $8.15M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $12.42M 10-Q · filed 2024-08-19 |
| 2023-09-30 | $12.82M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $16.03M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $12.29M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $30.92M 10-K · filed 2024-03-28 |
| 2022-09-30 | $35.07M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $35.79M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $12.69M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $12.91M 10-K · filed 2023-03-22 |
| 2021-09-30 | $13.40M 10-Q · filed 2021-11-16 |
| 2021-06-30 | $13.75M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $400.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $567.00K 10-K · filed 2022-03-15 |